Katrina Sleeman

2.7k total citations
36 papers, 1.7k citations indexed

About

Katrina Sleeman is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Katrina Sleeman has authored 36 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Epidemiology, 12 papers in Infectious Diseases and 10 papers in Molecular Biology. Recurrent topics in Katrina Sleeman's work include Influenza Virus Research Studies (24 papers), Respiratory viral infections research (23 papers) and Virology and Viral Diseases (5 papers). Katrina Sleeman is often cited by papers focused on Influenza Virus Research Studies (24 papers), Respiratory viral infections research (23 papers) and Virology and Viral Diseases (5 papers). Katrina Sleeman collaborates with scholars based in United States, Canada and Vietnam. Katrina Sleeman's co-authors include Larisa V. Gubareva, Alexander Klimov, Vasiliy P. Mishin, Arun K. Ghosh, Andrew D. Mesecar, Susan C. Baker, Bellur S. Prabhakar, Melissa M. Coughlin, Ha Nguyen and Michael E. Johnson and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Katrina Sleeman

36 papers receiving 1.7k citations

Peers

Katrina Sleeman
Katrina Sleeman
Citations per year, relative to Katrina Sleeman Katrina Sleeman (= 1×) peers Andrés Pizzorno

Countries citing papers authored by Katrina Sleeman

Since Specialization
Citations

This map shows the geographic impact of Katrina Sleeman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katrina Sleeman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katrina Sleeman more than expected).

Fields of papers citing papers by Katrina Sleeman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katrina Sleeman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katrina Sleeman. The network helps show where Katrina Sleeman may publish in the future.

Co-authorship network of co-authors of Katrina Sleeman

This figure shows the co-authorship network connecting the top 25 collaborators of Katrina Sleeman. A scholar is included among the top collaborators of Katrina Sleeman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katrina Sleeman. Katrina Sleeman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Gubareva, Larisa V., Katrina Sleeman, Zhu Guo, et al.. (2016). Drug Susceptibility Evaluation of an Influenza A(H7N9) Virus by Analyzing Recombinant Neuraminidase Proteins. The Journal of Infectious Diseases. 216(suppl_4). S566–S574. 33 indexed citations
3.
Okomo‐Adhiambo, Margaret, Vasiliy P. Mishin, Katrina Sleeman, et al.. (2016). Standardizing the influenza neuraminidase inhibition assay among United States public health laboratories conducting virological surveillance. Antiviral Research. 128. 28–35. 12 indexed citations
4.
Thor, Sharmi, Hieu Trung Nguyen, Amanda Balish, et al.. (2015). Detection and Characterization of Clade 1 Reassortant H5N1 Viruses Isolated from Human Cases in Vietnam during 2013. PLoS ONE. 10(8). e0133867–e0133867. 11 indexed citations
5.
Marjuki, Henju, Vasiliy P. Mishin, Anton Chesnokov, et al.. (2014). Characterization of Drug-Resistant Influenza A(H7N9) Variants Isolated From an Oseltamivir-Treated Patient in Taiwan. The Journal of Infectious Diseases. 211(2). 249–257. 66 indexed citations
6.
Nguyen, Ha, Tung Nguyen, Vasiliy P. Mishin, et al.. (2013). Antiviral Susceptibility of Highly Pathogenic Avian Influenza A(H5N1) Viruses Isolated from Poultry, Vietnam, 2009–2011. Emerging infectious diseases. 19(12). 1963–1971. 28 indexed citations
7.
Mishin, Vasiliy P., et al.. (2013). The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses. Antiviral Research. 101. 93–96. 27 indexed citations
8.
Sleeman, Katrina, Zhu Guo, John Barnes, et al.. (2013). R292K Substitution and Drug Susceptibility of Influenza A(H7N9) Viruses. Emerging infectious diseases. 19(9). 1521–1524. 61 indexed citations
9.
Garg, Shikha, Zack Moore, Nicole Lee, et al.. (2012). A Cluster of Patients Infected With I221V Influenza B Virus Variants With Reduced Oseltamivir Susceptibility—North Carolina and South Carolina, 2010–2011. The Journal of Infectious Diseases. 207(6). 966–973. 24 indexed citations
10.
Wang, Dayan, Katrina Sleeman, Jing‐Kai Huang, et al.. (2012). Neuraminidase inhibitor susceptibility testing of influenza type B viruses in China during 2010 and 2011 identifies viruses with reduced susceptibility to oseltamivir and zanamivir. Antiviral Research. 97(3). 240–244. 23 indexed citations
11.
Lindstrom, Stephen, Rebecca Garten, Amanda Balish, et al.. (2012). Human Infections with Novel Reassortant Influenza A(H3N2)v Viruses, United States, 2011. Emerging infectious diseases. 18(5). 834–837. 103 indexed citations
12.
Sleeman, Katrina, Tiffany G. Sheu, Zack Moore, et al.. (2011). Influenza B Viruses with Mutation in the Neuraminidase Active Site, North Carolina, USA, 2010–11. Emerging infectious diseases. 17(11). 2043–6. 30 indexed citations
13.
Graitcer, Samuel B., Larisa V. Gubareva, Laurie Kamimoto, et al.. (2010). Characteristics of Patients with Oseltamivir-Resistant Pandemic (H1N1) 2009, United States. Emerging infectious diseases. 17(2). 255–257. 62 indexed citations
14.
Gubareva, Larisa V., A. Angelica Trujillo, Margaret Okomo‐Adhiambo, et al.. (2010). Comprehensive assessment of 2009 Pandemic Influenza a (H1N1) Virus Drug Susceptibility in vitro. Antiviral Therapy. 15(8). 1151–1159. 73 indexed citations
15.
Okomo‐Adhiambo, Margaret, Ha Nguyen, Katrina Sleeman, et al.. (2009). Host cell selection of influenza neuraminidase variants: Implications for drug resistance monitoring in A(H1N1) viruses. Antiviral Research. 85(2). 381–388. 73 indexed citations
16.
Sleeman, Katrina, David A. Stein, Azaibi Tamin, et al.. (2009). Inhibition of measles virus infections in cell cultures by peptide-conjugated morpholino oligomers. Virus Research. 140(1-2). 49–56. 12 indexed citations
17.
Ghosh, Arun K., Jun Takayama, Kiira Ratia, et al.. (2009). Structure-Based Design, Synthesis, and Biological Evaluation of a Series of Novel and Reversible Inhibitors for the Severe Acute Respiratory Syndrome−Coronavirus Papain-Like Protease. Journal of Medicinal Chemistry. 52(16). 5228–5240. 109 indexed citations
18.
Ratia, Kiira, Scott D. Pegan, Jun Takayama, et al.. (2008). A noncovalent class of papain-like protease/deubiquitinase inhibitors blocks SARS virus replication. Proceedings of the National Academy of Sciences. 105(42). 16119–16124. 366 indexed citations
19.
Ghosh, Arun K., Gangli Gong, Valerie Grum‐Tokars, et al.. (2008). Design, synthesis and antiviral efficacy of a series of potent chloropyridyl ester-derived SARS-CoV 3CLpro inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(20). 5684–5688. 89 indexed citations
20.
Sleeman, Katrina & Michael D. Baron. (2004). The polymerase (L) protein of rinderpest virus interacts with the host cell protein striatin. Virology. 332(1). 225–234. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026